Literature DB >> 19228841

VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions.

Purnima Narasimhan1, Jing Liu, Yun Seon Song, Justin L Massengale, Pak H Chan.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral endothelial cells that line microvessels play an important role in maintaining blood flow homeostasis within the brain-forming part of the blood-brain barrier. These cells are injured by hypoxia-induced reperfusion, leading to blood-brain barrier breakdown and exacerbation of ischemic injury. We investigated the roles of vascular endothelial growth factor (VEGF) and the downstream extracellular signal-regulated kinase (ERK) protein after oxygen-glucose deprivation (OGD) in primary endothelial cells.
METHODS: Primary mouse endothelial cells were isolated and subjected to OGD. Western analysis of VEGF and ERK 1/2 protein levels was performed. Cells were transfected with VEGF small interference RNA. A terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling (TUNEL) assay and DNA fragmentation assay were used on mouse endothelial cells that overexpress copper/zinc-superoxide dismutase (SOD1).
RESULTS: VEGF protein expression was induced and its receptor, Flk-1, was stimulated by OGD. Phosphorylation of ERK 1/2 protein levels was upregulated. Inhibition of phosphorylated ERK (pERK) expression by U0126 reduced endothelial cell death by OGD. Transfection of small interfering RNA for VEGF also inhibited an increase in pERK, suggesting that VEGF acts via ERK. The TUNEL and DNA fragmentation assays showed a significant decrease in TUNEL-positivity in the SOD1-overexpressing endothelial cells compared with wild-type cells after OGD.
CONCLUSIONS: Our data suggest that OGD induces VEGF signaling via its receptor, Flk-1, and activates ERK via oxidative-stress-dependent mechanisms. Our study shows that in cerebral endothelial cells the ERK 1/2 signaling pathway plays a significant role in cell injury after OGD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228841      PMCID: PMC2663599          DOI: 10.1161/STROKEAHA.108.534644

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  32 in total

1.  VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.

Authors:  T Takahashi; H Ueno; M Shibuya
Journal:  Oncogene       Date:  1999-04-01       Impact factor: 9.867

Review 2.  Inflammatory mechanisms after ischemia and stroke.

Authors:  Gary H Danton; W Dalton Dietrich
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

Review 3.  Role of MAP kinase in neurons.

Authors:  K Fukunaga; E Miyamoto
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

4.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.

Authors:  C J Epstein; K B Avraham; M Lovett; S Smith; O Elroy-Stein; G Rotman; C Bry; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase.

Authors:  M Hetman; K Kanning; J E Cavanaugh; Z Xia
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

6.  Oxidative stress transiently decreases the IKK complex (IKKalpha, beta, and gamma), an upstream component of NF-kappaB signaling, after transient focal cerebral ischemia in mice.

Authors:  Yun S Song; Yong-Sun Lee; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2005-10       Impact factor: 6.200

7.  VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly.

Authors:  Dilaver Kaya; Yasemin Gürsoy-Ozdemir; Muge Yemisci; Neşe Tuncer; Sevinç Aktan; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2005-09       Impact factor: 6.200

8.  Temporal profile of angiogenesis and expression of related genes in the brain after ischemia.

Authors:  Takeshi Hayashi; Nobuo Noshita; Taku Sugawara; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2003-02       Impact factor: 6.200

Review 9.  Regulation of vascular permeability by vascular endothelial growth factors.

Authors:  D O Bates; S J Harper
Journal:  Vascul Pharmacol       Date:  2002-11       Impact factor: 5.773

10.  Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation.

Authors:  Haruo Aramoto; Jerome W Breslin; Peter J Pappas; Robert W Hobson; Walter N Durán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-20       Impact factor: 4.733

View more
  42 in total

Review 1.  Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease.

Authors:  Maria Teresa Rizzo; H Anne Leaver
Journal:  Mol Neurobiol       Date:  2010-04-21       Impact factor: 5.590

2.  Soluble epoxide hydrolase: sex differences and role in endothelial cell survival.

Authors:  Nandita C Gupta; Catherine M Davis; Jonathan W Nelson; Jennifer M Young; Nabil J Alkayed
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

3.  Nerve growth factor-induced protection of brain capillary endothelial cells exposed to oxygen-glucose deprivation involves attenuation of Erk phosphorylation.

Authors:  Shimon Lecht; Hadar Arien-Zakay; Cezary Marcinkiewicz; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2009-12-10       Impact factor: 3.444

Review 4.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

5.  Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice.

Authors:  Chang Rae Rho; Seungbum Kang; Ki Cheol Park; Keum-Jin Yang; Hyunsu Choi; Won-Kyung Cho
Journal:  J Ocul Pharmacol Ther       Date:  2015-02       Impact factor: 2.671

6.  Role of protease-activated receptor-1 in brain injury after experimental global cerebral ischemia.

Authors:  Jinhu Wang; Hang Jin; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Stroke       Date:  2012-07-17       Impact factor: 7.914

7.  Transplantation of neural stem cells that overexpress SOD1 enhances amelioration of intracerebral hemorrhage in mice.

Authors:  Takuma Wakai; Hiroyuki Sakata; Purnima Narasimhan; Hideyuki Yoshioka; Hiroyuki Kinouchi; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia.

Authors:  Jianping Wang; Xiaojie Fu; Chao Jiang; Lie Yu; Menghan Wang; Wei Han; Liu Liu; Jian Wang
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

9.  miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions.

Authors:  Eun-Ah Ye; Jena J Steinle
Journal:  Vision Res       Date:  2017-04-26       Impact factor: 1.886

10.  Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.

Authors:  B Nitzsche; C Gloesenkamp; M Schrader; M Ocker; R Preissner; M Lein; A Zakrzewicz; B Hoffmann; M Höpfner
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.